Key facts
- It has raised $9.3M; the latest was Later Stage VC ($9.3M) in Mar 2026.
- Notable investors include Bpifrance, Rockstart, Techmind, EIT Health, Euralimentaire — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Lifebloom
- ·The full record, as it builds
Funding rounds
No funding rounds for Lifebloom are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lifebloom
Developer of a rehabilitation mobility device designed to enable wheelchair-bound patients to stand, walk, and live upright independently. The company's devices combine physiotherapy with engineering using digital, mechanical, and medical technologies, enabling people with reduced mobility and dependent elderly people to walk and recover their autonomy safely and remain active.
- Sector
- Healthcare
- HQ
- Loos, France
- Founded
- 2016
- Employees
- 10
- Website
- lifebloom.eu/
- Ownership
- Privately Held (backing)
Lifebloom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lifebloom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lifebloom in its N-PORT filings yet. We sweep new filings monthly.